Developing biomaterials to improve healing

Biomaterials are engineered to interact with the body, and this project focuses on developing biomaterials that regulate the amount of glucose in a wound, because too much sugar can impede the healing process.

The biomaterials we have developed contain nanoparticles that shrink as the concentration of glucose increases, and testing is currently taking place to find out how insulin alters the original biomaterial. The aim will be to get the material to respond to raised sugar levels in the wound and release an appropriate amount of insulin to counteract the effects of the sugar. It is likely that the chemical components will have to be altered to accommodate the insulin, but this work is ongoing.